Intranasal absorption of granulocyte-colony stimulating factor (G-CSF) from powder formulations, in sheep

European Journal of Pharmaceutical Sciences

Volumn 6, Issue 1, 1998, Pages 1-10

  Gill, I J ^a   Fisher, A N ^a   Farraj, N ^a   Pitt, C G ^b   Davis, S S ^a   Illum, L ^a  

^a Danbiosyst UK Ltd   (United Kingdom)

^b AMGEN INC   (United States)

Author keywords

Conscious sheep; Granulocyte colony stimulating factor; Intranasal absorption; Leucocyte and neutrophil count; Plasma G CSF concentration

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LYSOPHOSPHATIDYLCHOLINE; STARCH MICROSPHERE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG FORMULATION; INTRANASAL DRUG ADMINISTRATION; LEUKOCYTE; LEUKOCYTE COUNT; NEUTROPHIL; NONHUMAN; PHARMACOKINETICS; POWDER; PRIORITY JOURNAL; SHEEP; SUBCUTANEOUS DRUG ADMINISTRATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BIOLOGICAL AVAILABILITY; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; INJECTIONS, SUBCUTANEOUS; LYSOPHOSPHOLIPIDS; POWDERS; SHEEP; SOLUTIONS; STARCH;

EID: 0031973807     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0987(97)00057-2     Document Type: Article

References (22)

1. Bjork E, Bjurstrom S, Edman P. Morphologic examination of rabbit nasal mucosa after nasal administration of degradable starch microspheres. Int J Pharm. 75:1991;73-80.
2. Chandler SG. Intranasal peptide absorption: Mechanisms of enhancement. Ph.D. Thesis. 1992;143-166. submitted to the University of Nottingham Ch. 5.
3. Chien YW, Su KSE, Chang SF. Nasal Systemic Drug Delivery. 1989;1-26 Marcel Dekker, New York.
4. Edman P, Bjork E, Ryden L. Microspheres as a nasal delivery system for peptide drugs. J Cont Rel. 21:1992;165-172.
5. Farraj NF, Johansen BR, Davis SS, Illum L. Nasal administration of insulin using bioadhesive microspheres as a delivery system. J Cont Rel. 13:1990;253-261.
6. Fix JA, Engle K, Porter PA, Leppert PS, Selk SJ, Gardner CR, Alexander J. Acylcarnitines: drug absorption-enhancing agents in the gastrointestinal tract. Am J Phys. 251:1986;G332-G430.
7. Funkhouser JD, Batenburg JJ, Van Golde LMG. Acylation of 1-palmitoyl-L-lysophosphatidylglycerol in alveolar type II cells from rat lung. Biochim Biophys Acta. 666:1981;1-6.
8. Iida J, Sailki I, Ishihara C, Azuma I. Protective activity of recombinant cytokines against Sendai virus and herpes simplex virus (HSV) infections in mice. Vaccine. 7:1989;229-233.
9. Illum L, Jorgensen H, Bisgaard H, Krogsgaard O, Rossing N. Bioadhesive microspheres as a potential nasal drug system. Int J Pharm. 39:1987;189-199.
10. Illum L, Farraj NF, Critchley H, Davis SS. Nasal administration of gentamicin using a novel microsphere system. Int J Pharm. 46:1988;261-265.
11. Illum L, Farraj NF, Davis SS, Johansen BR, O'Hagan DT. Investigation of the nasal absorption of biosynthetic human growth hormone in sheep; use of a bioadhesive microsphere delivery system. Int J Pharm. 63:1990;207-211.
12. Illum L, Davis SS. Intranasal Insulin, Clinical Pharmacokinetics. Clin Pharmacokinet. 23:(1):1992;30-41.
13. Illum L, Farraj NF, Fisher AN, Gill I, Miglietta M, Benedetti LM. Hyaluronic acid ester microspheres as a nasal delivery system for insulin. J Cont Rel. 29:1994;133-141.
14. LeCluyse EL, Appel LE, Sutton SC. Relationship between drug absorption activity and membrane perturbing effects of acylcarnitines. Pharm Res. 8:1991;84-87.
15. Longenecker JP, Moses AC, Flier JS, Silver RD, Carey MC, Dubovi EJ. Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep. J Pharm Sci. 76:1987;351-355.
16. Machida M, Sano K, Arakawa M, Hayashi M, Awazu S. Absorption of recombinant human Granulocyte Colony-stimulating Factor (rhG-CSF) from rat nasal mucosa. Pharm Res. 10:1993;1372-1377.
17. Niven RW, Lott FD, Ip AY, Cribbs JM. Pulmonary delivery of powders and solutions containing recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) to the rabbit. Pharm Res. 11:1994;1101-1109.
18. O'Hagan DT, Critchley H, Farraj NF, Fisher AN, Johansen BR, Davis SS, Illum L. Nasal absorption enhancers for biosynthetic human growth hormone in rats. Phar Res. 7:1990;772-776.
19. Ryden L, Edman P. Potential use of polymers and spheres as nasal drug delivery systems. Proc Int Symp Control Rel Bioactive Materials. 18:1991;495-496.
20. Stafford ER, Fanni T, Dennis ED. Interfacial properties and critical micelle concentration of Lysophospholipids. Biochemistry. 28:(12):1989;5113-5120.
21. Watanabe Y, Matsumoto Y, Kikuchi R, Kiriyama M, Nakagawa K, Nomura H, Maruyama K, Matsumoto M. Pharmokinetics and Pharmacodynamics of Recombinant Granulocyte Colony-Stimulating Factor (rhG-CSF) following Intranasal Administration in Rabbits. J Drug Targeting. 3:1995;231-238.
22. Watanabe Y, Kikuchi R, Kiriyama M, Nakagawa K, Oe J, Matsumoto M, Nomura H, Maruyama K, Matsumoto Y. Increase in Total Blood Leukocyte Count Following Intranasal Administration of Recombinant Human Granulocyte Colony-Stimulating Factor (rhG-CSF) in Rabbits with Cyclophosphamide-Induced Leukopenia. Biol Pharm Bull. 18:(8):1995;1084-1088.